162 related articles for article (PubMed ID: 30135180)
21. Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4.
Dias JD; Hemminki O; Diaconu I; Hirvinen M; Bonetti A; Guse K; Escutenaire S; Kanerva A; Pesonen S; Löskog A; Cerullo V; Hemminki A
Gene Ther; 2012 Oct; 19(10):988-98. PubMed ID: 22071969
[TBL] [Abstract][Full Text] [Related]
22. Effect of electroacupuncture on leptin resistance in rats with diet-induced obesity.
Gong M; Wang X; Mao Z; Shao Q; Xiang X; Xu B
Am J Chin Med; 2012; 40(3):511-20. PubMed ID: 22745067
[TBL] [Abstract][Full Text] [Related]
23. Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer.
van Hooren L; Sandin LC; Moskalev I; Ellmark P; Dimberg A; Black P; Tötterman TH; Mangsbo SM
Eur J Immunol; 2017 Feb; 47(2):385-393. PubMed ID: 27873300
[TBL] [Abstract][Full Text] [Related]
24. Age-related changes in acute central leptin effects on energy balance are promoted by obesity.
Rostás I; Tenk J; Mikó A; Füredi N; Soós S; Solymár M; Lengyel A; Székely M; Gaszner B; Feller D; Pétervári E; Balaskó M
Exp Gerontol; 2016 Dec; 85():118-127. PubMed ID: 27780783
[TBL] [Abstract][Full Text] [Related]
25. Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.
Rakhmilevich AL; Felder M; Lever L; Slowinski J; Rasmussen K; Hoefges A; Van De Voort TJ; Loibner H; Korman AJ; Gillies SD; Sondel PM
J Immunol; 2017 Feb; 198(4):1575-1584. PubMed ID: 28062694
[TBL] [Abstract][Full Text] [Related]
26. Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling.
Vauthier V; Roujeau C; Chen P; Sarkis C; Migrenne S; Hosoi T; Ozawa K; Rouillé Y; Foretz M; Mallet J; Launay JM; Magnan C; Jockers R; Dam J
Mol Metab; 2017 Jan; 6(1):159-172. PubMed ID: 28123946
[TBL] [Abstract][Full Text] [Related]
27. A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.
Carosella ED; Ploussard G; LeMaoult J; Desgrandchamps F
Eur Urol; 2015 Aug; 68(2):267-79. PubMed ID: 25824720
[TBL] [Abstract][Full Text] [Related]
28. Systemic delivery of chTNT-3/CpG immunoconjugates for immunotherapy in murine solid tumor models.
Jang JK; Khawli LA; Canter DC; Hu P; Zhu TH; Wu BW; Angell TE; Li Z; Epstein AL
Cancer Immunol Immunother; 2016 May; 65(5):511-23. PubMed ID: 26960932
[TBL] [Abstract][Full Text] [Related]
29. Peripheral Leptin Signaling Mediates Formalin-Induced Nociception.
Hu ZJ; Han W; Cao CQ; Mao-Ying QL; Mi WL; Wang YQ
Neurosci Bull; 2018 Apr; 34(2):321-329. PubMed ID: 29204732
[TBL] [Abstract][Full Text] [Related]
30. Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice.
Turbitt WJ; Boi SK; Gibson JT; Orlandella RM; Norian LA
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34064933
[TBL] [Abstract][Full Text] [Related]
31. Immunosensitization with a Bcl-2 small molecule inhibitor.
Begley J; Vo DD; Morris LF; Bruhn KW; Prins RM; Mok S; Koya RC; Garban HJ; Comin-Anduix B; Craft N; Ribas A
Cancer Immunol Immunother; 2009 May; 58(5):699-708. PubMed ID: 18807035
[TBL] [Abstract][Full Text] [Related]
32. Leptin-mediated inflammatory signaling crucially links visceral fat inflammation to obesity-associated β-cell dysfunction.
Tian YF; Chang WC; Loh CH; Hsieh PS
Life Sci; 2014 Oct; 116(1):51-8. PubMed ID: 25123537
[TBL] [Abstract][Full Text] [Related]
33. Obesity alters immune and metabolic profiles: New insight from obese-resistant mice on high-fat diet.
Boi SK; Buchta CM; Pearson NA; Francis MB; Meyerholz DK; Grobe JL; Norian LA
Obesity (Silver Spring); 2016 Oct; 24(10):2140-9. PubMed ID: 27515998
[TBL] [Abstract][Full Text] [Related]
34. Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse.
Igel M; Becker W; Herberg L; Joost HG
Endocrinology; 1997 Oct; 138(10):4234-9. PubMed ID: 9322935
[TBL] [Abstract][Full Text] [Related]
35. Ctla-4 blockade plus adoptive T-cell transfer promotes optimal melanoma immunity in mice.
Mahvi DA; Meyers JV; Tatar AJ; Contreras A; Suresh M; Leverson GE; Sen S; Cho CS
J Immunother; 2015; 38(2):54-61. PubMed ID: 25658614
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma.
Murillo O; Arina A; Hervas-Stubbs S; Gupta A; McCluskey B; Dubrot J; Palazón A; Azpilikueta A; Ochoa MC; Alfaro C; Solano S; Pérez-Gracia JL; Oyajobi BO; Melero I
Clin Cancer Res; 2008 Nov; 14(21):6895-906. PubMed ID: 18980984
[TBL] [Abstract][Full Text] [Related]
37. The thymoprotective function of leptin is indirectly mediated via suppression of obesity.
Sreenivasan J; Schlenner S; Franckaert D; Dooley J; Liston A
Immunology; 2015 Sep; 146(1):122-9. PubMed ID: 26059465
[TBL] [Abstract][Full Text] [Related]
38. Tbc1d1 deletion suppresses obesity in leptin-deficient mice.
Dokas J; Chadt A; Joost HG; Al-Hasani H
Int J Obes (Lond); 2016 Aug; 40(8):1242-9. PubMed ID: 27089993
[TBL] [Abstract][Full Text] [Related]
39. FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model.
Sow HS; Benonisson H; Breukel C; Visser R; Verhagen OJHM; Bentlage AEH; Brouwers C; Claassens JWC; Linssen MM; Camps M; van Hall T; Ossendorp F; Fransen MF; Vidarsson G; Verbeek JS
Int J Cancer; 2019 Jan; 144(2):345-354. PubMed ID: 30259976
[TBL] [Abstract][Full Text] [Related]
40. Cholesterol metabolism and Cx43, Cx46, and Cx50 gap junction protein expression and localization in normal and diabetic and obese ob/ob and db/db mouse testes.
Pelletier RM; Akpovi CD; Chen L; Vitale ML
Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E21-E38. PubMed ID: 28851737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
